BiondVax Pharmaceuticals Ltd. (BVXV), a development-stage biopharmaceutical company, has surged 12.50% in the premarket trading session. Consequently, BVXV stock is trading at $2.61 at the time of the writing. The surge could be attributed to the successful closing of an underwritten offering of ADSs. On
Reliance Global Group, Inc. (RELI), a company engaged in the acquisition and management of wholesale and retail insurance agencies, has declined 5.09% in aftermarket trading session. Consequently, RELI stock is trading at $4.1 at the time of the wiring. On Thursday, RELI closed the day
Can-Fite BioPharma Ltd. (CANF), a clinical-stage biopharmaceutical company, has plunged 13.49% during the aftermarket trading session. As a result, CANF stock is trading at $1.86 at the time of the writing. The decline could be attributed to the profit-taking factor after CANF rocketed 69.29% during
Moderna, Inc. (MRNA), a biotechnology company, has soared 5.07% in the premarket trading session. As a result, MRNA stock is trading at $309.74 at the time of the writing. The increase could be attributed to the company’s announcement of preliminary booster data to address the
Origin Materials, Inc. (ORGN), a carbon-negative materials company, has surged 4.01% in the premarket trading session. As a result, ORGN stock is trading at $6.23 at the time of the writing. Data suggests that short-term investors are the major contributor to this surge. On Friday,
ObsEva SA (OBSV), a biopharmaceutical company, has increased by 7.76% in the premarket trading session. As a result, OBSV stock is trading at $2.36 at the time of the writing. The increase is attributable to the announcement of positive CHMP opinion for Linzagolix. On Thursday,
Star Equity Holdings, Inc. (STRR), which provides healthcare solutions, has gained an increase of 4.31% in aftermarket trading session. As a result, STRR stock is trading at $2.66 at the time of the writing. The increase could be attributed to insider trading as the volume
Applied DNA Sciences, Inc. (APDN), a company that develops and markets DNA-based technology solutions, has surged 11.02% in aftermarket trading session. Consequently, APDN stock is trading at $5.64 at the time of the writing. The surge could be attributed to the announcement of fiscal results.
Petros Pharmaceuticals, Inc. (PTPI), a pharmaceutical company, has declined 5.56% in aftermarket trading session. As a consequence, PTPI stock is trading at $2.38 at the time of the writing. On Wednesday, PTPI gained an increase of 7.69% during the regular trading session and closed the
Vivos Therapeutics, Inc. (VVOS) experienced a decline of 9.61% in the aftermarket following the announcement of the company’s participation at the Benzinga Global Small Cap Conference. However, the last trading session concluded at $2.29 with a decrease of 8.03%. Benzinga Global Small-Cap Conference – What’s
News IMC are non-trivial topics and publications about how you make money and properly dispose of it. We tell about business and entrepreneurship, start-ups, success stories. We also specialize in economic news.
Allrights reserved ©2024, Powered by Smart TechOne
